Watch MEDP. Know when insiders buy.
One email the day a filing lands. Free.
Work order
51
WATCH · insiders 25, shorts 77
Insiders, 90 days
−$51.5M
net selling · 0 buys, 11 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
2 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
MKT CAP $16.5BP/E 34.7DIV YIELD —FCF YIELD 4.28%REV TTM $2.8B +24.7%NET INCOME $491.5M +17.5%NET CASH $340.8M52W 393.42 – 620.75NEXT EARNINGS Oct 19 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $707.3M | +17.2% | — | $146.8M | $121.4M | +34.5% | 4.25 | $162M | $23.9M | $138.1M | Jul 23 |
| Q1 2026 · Mar 31 | $706.6M | +26.5% | — | $141.5M | $123.9M | +8.1% | 4.28 | $151.8M | $6.8M | $145M | Jul 23 |
| Q4 2025 · Dec 31derived | $708.5M | +32.0% | — | $153.3M | $135.1M | +15.5% | 4.64 | $192.7M | $4.5M | $188.1M | Feb 10 |
| Q3 2025 · Sep 30 | $659.9M | +23.7% | — | $141.8M | $111.1M | +15.3% | 3.86 | $246.2M | $10.7M | $235.5M | Oct 23 |
| Q2 2025 · Jun 30 | $603.3M | +14.2% | — | $126.3M | $90.3M | +2.2% | 3.10 | $148.5M | $6.1M | $142.4M | Jul 23 |
| Q1 2025 · Mar 31 | $558.6M | +9.3% | — | $113.5M | $114.6M | +11.7% | 3.67 | $125.8M | $10M | $115.8M | Jul 23 |
| Q4 2024 · Dec 31derived | $536.6M | +7.7% | — | $125.4M | $117M | +49.5% | 3.67 | $190.7M | $7.6M | $183M | Feb 10 |
| Q3 2024 · Sep 30 | $533.3M | +8.3% | — | $112.3M | $96.4M | +36.7% | 3.01 | $149.1M | $10.5M | $138.5M | Oct 23 |
| Q2 2024 · Jun 30 | $528.1M | — | — | $105.2M | $88.4M | — | 2.75 | $116.4M | $12.9M | $103.5M | Oct 23 |
| Q1 2024 · Mar 31 | $511M | — | — | $104.1M | $102.6M | — | 3.20 | $152.7M | $5.5M | $147.2M | Oct 23 |
| Q4 2023 · Dec 31derived | $498.4M | — | — | $87.3M | $78.3M | — | 2.46 | $156.4M | $10M | $146.4M | Feb 10 |
| Q3 2023 · Sep 30 | $492.5M | — | — | $84.9M | $70.5M | — | 2.22 | $114.4M | $8.7M | $105.7M | Oct 22 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $2.5B | — | $534.9M | $451.1M | 17.8% | 15.28 | $713.2M | $31.4M | $681.9M | $917.4M | — |
| FY2024 · to Dec 31 | $2.1B | — | $446.9M | $404.4M | 19.2% | 12.63 | $608.8M | $36.5M | $572.3M | $169.9M | — |
| FY2023 · to Dec 31 | $1.9B | — | $336.8M | $282.8M | 15.0% | 8.88 | $433.4M | $36.6M | $396.7M | $144M | — |
| FY2022 · to Dec 31 | $1.5B | — | $278.7M | $245.4M | 16.8% | 7.28 | $388.1M | $36.9M | $351.2M | $847.8M | — |
| FY2021 · to Dec 31 | $1.1B | — | $198.6M | $181.8M | 15.9% | 4.81 | $263.3M | $28.3M | $235.1M | $62.1M | — |
| FY2020 · to Dec 31 | $925.9M | — | $167M | $145.4M | 15.7% | 3.84 | $258.7M | $31.3M | $227.3M | $98.3M | — |
Every number comes from Medpace Holdings, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.